[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 21, 2016

Study Completion Date

December 21, 2016

Conditions
Gynecologic Cancer
Interventions
RADIATION

[18F]Fluorothymidine (FLT) PET/CT Imaging

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02108457 - [18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers | Biotech Hunter | Biotech Hunter